Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Artiva Biotherapeutics

ARTVNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$10.67

0.707.02%

At close: -

$10.67

0.000.00%

After Hours: Jan 3, 4:01 PM EDT

Artiva Biotherapeutics (ARTV) Forecast

News

Earnings Artiva Biotherapeutics (ARTV) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Artiva Biotherapeutics (NASDAQ:ARTV) Stock

Artiva Biotherapeutics Stock (NASDAQ: ARTV)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, December 30, 2024

This American Airlines Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday
Avi Kapoor
This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Avi Kapoor
HC Wainwright & Co. Initiates Coverage On Art...
Benzinga Newsdesk

Wednesday, November 13, 2024

Artiva Biotherapeutics shares are trading low...
Benzinga Newsdesk
Needham Reiterates Buy on Artiva Biotherapeut...
Benzinga Newsdesk

Tuesday, November 12, 2024

Artiva Biotherapeutics Q3 EPS $(0.92) Misses ...
Benzinga Newsdesk

Friday, August 30, 2024

Needham Reiterates Buy on Artiva Biotherapeut...
Benzinga Newsdesk

Thursday, August 29, 2024

Artiva Biotherapeutics Q2 EPS $(22.00) Down F...
Benzinga Newsdesk

Tuesday, August 13, 2024

Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch
Vandana Singh
Needham Initiates Coverage On Artiva Biothera...
Benzinga Newsdesk
Wedbush Initiates Coverage On Artiva Biothera...
Benzinga Newsdesk
Cantor Fitzgerald Initiates Coverage On Artiv...
Benzinga Newsdesk
TD Cowen Initiates Coverage On Artiva Biother...
Benzinga Newsdesk
Jefferies Initiates Coverage On Artiva Biothe...
Benzinga Newsdesk

Friday, July 19, 2024

Trading Halt: Halt status updated at 10:10:00...
Benzinga Newsdesk
Reported Earlier, Artiva Biotherapeutics Pric...
Benzinga Newsdesk

Thursday, July 18, 2024

Artiva Biotherapeutics, Inc To Start Trading Tomorrow
Benzinga Insights

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved